CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-ζ chain expression

被引：27

作者：

Schüle J.M. ^{[1
,2
]}

Bergkvist L. ^{[1
,2
]}

Håkansson L. ^{[3
]}

Gustafsson B. ^{[4
]}

Håkansson A. ^{[3
]}

机构：

[1] Department of Surgery, Central Hospital

[2] Center for Clinical Research, Uppsala University

[3] Department of Oncology, University Hospital of Linkoping

[4] Department of Pathology and Cytology, University Hospital of Linkoping

来源：

Journal of Translational Medicine | / 2卷 / 1期

关键词：

Breast Cancer Patient; Sentinel Node; CD28 Expression; Sentinel Node Biopsy; Germinal Center;

D O I：

10.1186/1479-5876-2-45

中图分类号：

学科分类号：

摘要：

Background: Immunosuppression is documented in several malignant diseases, including breast cancer. Subsequently, future therapeutic concepts might include immunological approaches. However, detailed knowledge about tumor immunogenicity and host immunoreactivity, and how to assess these adequately, is still limited. We studied CD28 and CD3-ζ expression in sentinel node biopsies (SNB) from breast cancer patients to analyze tumor-related changes in T cell activity. Method: 25 women underwent surgery for primary breast cancer, including SNB. Frozen sections from 21 sentinel nodes could be analyzed with a double-staining technique. CD28 expression was studied in CD4+ and CD8+ T-lymphocyte subsets and compared with CD3-ζ expression in three specified nodal regions. Results: The degree of CD28 expression varied between the different lymph node areas. The lowest degree of CD28 expression was observed in CD4+ T-lymphocytes in the paracortex and germinal centers. Here, a good agreement with CD3-ζ expression was found. A higher CD28 expression was noted in CD4+ T-cells in the primary follicles, where concordance with CD3-ζ expression was weaker. The CD8+ T-lymphocyte subset displayed generally a higher degree of CD28 expression than the CD4+ subset. Conclusion: Sentinel lymph nodes from breast cancer patients displayed local immunosuppression of varying extent. In the areas with the lowest degree of CD28 expression an accordingly low CD3-ζ expression was found. The SNB might prove an important diagnostic tool for the evaluation of interactions between tumor and the host immune system, helping to select patients who might benefit from adjuvant immunotherapy. © 2004 Schüle et al; licensee BioMed Central Ltd.

引用

页数：9

共 40 条

[1]

Pawelec G., Heinzel S., Kiessling R., Muller L., Ouyang Q., Zeuthen J., Escape Mechanisms in Tumor Immunity: A Year 2000 Update, Critical Reviews in Oncogenesis, 11, pp. 97-133, (2000)

[2]

Kurt R.A., Urba W.J., Smith J.W., Schoof D.D., Peripheral T Lymphocytes from Women with Breast Cancer Exhibit Abnormal Protein Expression of Several Signaling Molecules, Int. J. Cancer, 78, pp. 16-20, (1998)

[3]

Lopez C.B., Rao T.D., Feiner H., Shapiro R., Marks J.R., Frey A.B., Repression of Interleukin-2 mRNA Translation in Primary Human Breast Carcinoma Tumor-Infiltrating Lymphocytes, Cellular Immunol., 190, pp. 141-155, (1998)

[4]

Wolfram R.M., Budinsky A.C., Brodowicz T., Kubista M., Kostler W.J., Kichler-Lakomi C., Hellan M., Kahlhammer G., Wiltschke C., Zielinski C.C., Defective Antigen Presentation Resulting from Impaired Expression of Costimulatory Molecules in Breast Cancer, Int. J. Cancer, 88, pp. 239-244, (2000)

[5]

Reichert T.E., Day R., Wagner E.M., Whiteside T.L., Absent or Low Expression of the Zeta Chain in T Cells at the Tumor Site Correlates with Poor Survival in Patients with Oral Carcinoma, Cancer Res., 58, pp. 5344-5347, (1998)

[6]

Matsuda M., Petersson M., Lenkei R., Taupin J.-L., Magnusson I., Mellstedt H., Anderson P., Kiessling R., Alterations in the Signal-Transducing Molecules of T Cells and NK Cells in Colorectal Tumor-Infiltrating, Gut Mucosal and Peripheral Lymphocytes: Correlation with the Stage of the Disease, Int. J. Cancer, 61, pp. 765-772, (1995)

[7]

June C.H., Ledbetter J.A., Linsley P.S., Thompson C.B., Role of the CD28 receptor in T-cell activation, Immunology Today, 11, pp. 211-216, (1990)

[8]

June C.H., Bluestone J.A., Nadler L.M., Thompson C.B., The B7 and CD28 receptor families, Immunology Today, 15, pp. 321-331, (1994)

[9]

Turka L.A., Ledbetter J.A., Lee K., June C.H., Thompson C.B., CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature lymphocytes, J. Immunol., 144, pp. 1646-1653, (1990)

[10]

Judge T.A., Tang A., Turka L.A., Immunosuppression through Blockade of CD28:B7-Mediated Costimulatory Signals, Immunol. Res., 15, pp. 38-49, (1996)

← 1 2 3 4 →